About XARlabs
XARlabs is a company based in London (United Kingdom) founded in 2025. XARlabs has raised $2.3 million across 1 funding round from investors including Eric Johnson and Eka Ventures. XARlabs offers products and services including simXAR and Surgical Planning Products. XARlabs operates in a competitive market with competitors including Fundamental Surgery, Zeta Surgical, Simulatory, Precision OS and Osgenic, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Simxar Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.3 M (USD)
in 1 rounds
-
Latest Funding Round
$2.3 M (USD), Seed
Feb 10, 2025
-
Investors
Eka Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of XARlabs
XARlabs offers a comprehensive portfolio of products and services, including simXAR and Surgical Planning Products.
Offers surgical rehearsals and training with high-precision simulations.
Under research for enhancing surgical procedures and patient consenting.
Funding Insights of XARlabs
XARlabs has successfully raised a total of $2.3M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.3 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in XARlabs
XARlabs has secured backing from 2 investors, including angel and venture fund investors. Prominent investors backing the company include Eric Johnson and Eka Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused om consumer tech sector
|
Locked | Locked | Locked | |
|
EJ
Eric Johnson |
-
|
Locked | Locked | Locked |
Investor details for XARlabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by XARlabs
Investment portfolio details for XARlabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - XARlabs
Detailed financials for XARlabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xarlabs Comparisons
Peer comparison for XARlabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of XARlabs
XARlabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fundamental Surgery, Zeta Surgical, Simulatory, Precision OS and Osgenic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based surgical simulation is enabled via VR and haptics.
|
|
| Locked | Locked | Locked |
AI-based navigation and robotics systems for surgeries are developed.
|
|
| Locked | Locked | Locked |
AI-driven surgical training is delivered via VR simulations.
|
|
| Locked | Locked | Locked |
Orthopedic simulations are delivered via VR, MR, and AR platforms.
|
|
| Locked | Locked | Locked |
VR-based simulators for surgical training are provided.
|
|
| Locked | Locked | Locked |
VR-integrated simulations for surgical training are developed.
|
Detailed competitors of XARlabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xarlabs
Complete news archive for XARlabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about XARlabs
XARlabs was founded in 2025.
XARlabs is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
XARlabs is a funded company, having raised a total of $2.3M across 1 funding round to date.
XARlabs was founded in 2025 in London, United Kingdom. Mixed reality technologies are focused on by the company within the healthcare sector. The simXAR platform is provided to enable high-precision simulations for surgical rehearsals, medical training, and patient consenting processes. 2D medical imaging data is transformed into immersive 3D environments to support these operations.
XARlabs's top competitors include Fundamental Surgery, Zeta Surgical and Precision OS.
XARlabs offers simXAR and Surgical Planning Products.
XARlabs has 2 investors. Key investors include Eric Johnson, and Eka Ventures.